Novo Nordisk rolls out long-awaited Tresiba, aiming for blockbuster market share

Tracy Staton Novo Nordisk finally launched its next-gen diabetes treatment Tresiba in the U.S., approved by the FDA last September. The Danish drugmaker has high hopes ...

Victoza weight-loss nod could rescue Novo from Tresiba delay, CEO says

Tracy Staton Novo Nordisk and its profit-growth plans hit a roadblock earlier this year when the FDA refused to approve its new diabetes drug, Tresiba, without a new safety study. But ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS